Literature DB >> 19071255

Lung infections after cancer chemotherapy.

Sandro Vento1, Francesca Cainelli, Zelalem Temesgen.   

Abstract

Lung infections can be severe consequences of chemotherapy-induced immune defects. Aetiological causes of infection include bacteria (most commonly Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Nocardia species), viruses (eg, respiratory syncytial virus, parainfluenza virus, influenza virus A and B, and cytomegalovirus), and fungi (eg, Aspergillus, Fusarium, and Mucorales species, and Pneumocystis jirovecii). Most infections are caused by bacteria (especially Gram negative), but viruses are being increasingly identified. Diagnosis is difficult and frequently time-consuming. Treatment can be ineffective for many patients, particularly those with fungal infection. The greatest hope for the future is the availability of more targeted anticancer drugs that have fewer side-effects on the immune system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19071255     DOI: 10.1016/S1470-2045(08)70255-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  38 in total

1.  A human surfactant peptide-elastase inhibitor construct as a treatment for emphysema.

Authors:  Frank Guarnieri; Jean L Spencer; Edgar C Lucey; Matthew A Nugent; Phillip J Stone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

Review 3.  Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.

Authors:  Justin L Wong; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-03-01       Impact factor: 2.878

4.  The Pseudomonas aeruginosa PrrF Small RNAs Regulate Iron Homeostasis during Acute Murine Lung Infection.

Authors:  Alexandria A Reinhart; Angela T Nguyen; Luke K Brewer; Justin Bevere; Jace W Jones; Maureen A Kane; F Heath Damron; Mariette Barbier; Amanda G Oglesby-Sherrouse
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

Review 5.  Changes in critically ill cancer patients' short-term outcome over the last decades: results of systematic review with meta-analysis on individual data.

Authors:  Michaël Darmon; Aurélie Bourmaud; Quentin Georges; Marcio Soares; Kyeongman Jeon; Sandra Oeyen; Chin Kook Rhee; Pascale Gruber; Marlies Ostermann; Quentin A Hill; Pieter Depuydt; Christelle Ferra; Anne-Claire Toffart; Peter Schellongowski; Alice Müller; Virginie Lemiale; Djamel Mokart; Elie Azoulay
Journal:  Intensive Care Med       Date:  2019-05-29       Impact factor: 17.440

6.  Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells.

Authors:  David M Peereboom; Tyler J Alban; Matthew M Grabowski; Alvaro G Alvarado; Balint Otvos; Defne Bayik; Gustavo Roversi; Mary McGraw; Pengjing Huang; Alireza M Mohammadi; Harley I Kornblum; Tomas Radivoyevitch; Manmeet S Ahluwalia; Michael A Vogelbaum; Justin D Lathia
Journal:  JCI Insight       Date:  2019-11-14

7.  Management of Acute Respiratory Failure in Patients With Hematological Malignancy.

Authors:  Rakesh Vadde; Stephen M Pastores
Journal:  J Intensive Care Med       Date:  2016-07-07       Impact factor: 3.510

8.  Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations.

Authors:  Ramon Kaneno; Galina V Shurin; Irina L Tourkova; Michael R Shurin
Journal:  J Transl Med       Date:  2009-07-10       Impact factor: 5.531

9.  Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.

Authors:  Xiang Li; Haitao Li; Shengqing Li; Feng Zhu; Dong Joon Kim; Hua Xie; Yan Li; Janos Nadas; Naomi Oi; Tatyana A Zykova; Dong Hoon Yu; Mee-Hyun Lee; Myoung Ok Kim; Lei Wang; Weiya Ma; Ronald A Lubet; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  Carcinogenesis       Date:  2012-09-07       Impact factor: 4.944

10.  Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy.

Authors:  Akinobu Kamei; Geli Gao; Geoffrey Neale; Lip Nam Loh; Peter Vogel; Paul G Thomas; Elaine I Tuomanen; Peter J Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.